SlideShare a Scribd company logo
STATES OF
pharmaceutical
Materials
Dr. L.T.M. Muungo
States of Matter
. Binding Forces Between Molecules
. Solids and the Crystalline State
. Phase Equilibria and the Phase Rule
Objectives of the lecture
After completion of this chapter, the students should be able to:
Describe the solid state , crystallinity, solvates and polymorphism
Understand phase equilibria and phase transitions between the three
main states of matter
Understand the phase rule and its application to different systems
containing multiple components.
Comparison of Gases, Liquids and Solids
. Gases are compressible fluids. Their molecules are widely separated.
. Liquids are relatively incompressible fluids. Their molecules are more tightly packed.
. Solids are nearly incompressible and rigid. Their molecules or ions are in close contact
and do not move.
In order for molecules to exist in aggregates in gases, liquids
and solids Intermolecular forces must exist
Repulsive and Attractive Forces
. As two atoms or molecules are brought closer
together, the opposite charges and binding
forces in the two molecules are closer
together than the similar charges and forces,
causing the molecules to attract one another.
. The negatively charged electron clouds of
molecules largely govern the balance
(equilibrium) forces between the two
molecules
Ideal Gas Equation
1
V
Boyle’s law: P a (at constant n and T)
Charles’ law: V a T (at constant n and P)
Avogadro’s law: V a n (at constant P and T)
P V P V R is the gas
constant
1 1 2 2
PV = nRT
=
T T2
1
Gaseous state
. The conditions 0 0C and 1 atm are called standard temperature and
pressure (STP).
. Experiments show that at STP, 1 mole of an ideal gas occupies 22.414
L.
PV = nRT
(1 atm)(22.414L)
PV
nT (1 mol)(273.15 K)
=
R =
R = 0.082057 L • atm / (mol • K)
Gaseous state
What is the volume (in liters) occupied by 49.8 g of HCl at STP?
T = 0 0C = 273.15 K
1 atm ≈ 760.001 mm-Hg
P = 1 atm
PV = nRT
nRT
1 mol HCl
n = 49.8 g x = 1.37 mol
36.45 g HCl
V =
P
L•atm
mol•K
1.37 mol x 0.0821 x 273.15 K
V =
1 atm
V = 30.7 L
9
Gaseous state
P V
P V 2 2
1 1
=
T2
T1
Liquefaction of Gases
. The critical temperature (T ) is the temperature above which the gas cannot be
c
made to liquefy, OR is the temperature above which the liquid cannot longer exist
. The critical pressure (P ) is the minimum pressure required to liquefy a gas at its
c
critical temperature.
. critical temperature (T ) of water is 374°C, or 647 K, and its critical pressure is
c
218 atm,
SOLIDS & CRYSTALLINE STATE
Pharmaceutical Drugs: more than 80% are solid formulations
Solids and the crystalline state
. A crystalline solid possesses rigid and long-range order.
. In a crystalline solid, atoms, molecules or ions occupy specific
(predictable) positions.
. An amorphous solid does not possess a well-defined arrangement
and long-range molecular order.
Classification of Solids
Crystalline Amorphous
A unit cell is the basic repeating structural unit of a crystalline solid.
lattice
point
At lattice points:
• Atoms
• Molecules
• Ions
Unit Cell Unit cells in 3 dimensions
The crystal lattice of sodium chloride NaCl
Cl
Na
Crystal forms
The various crystal forms are divide to basic 7 unit according to its symmetry
iodoform
urea
NaCl
iodine
Be Al (SiO )
3 2 3 6
sucrose Boric acid
Types of Crystals
Ionic Crystals
• Lattice points occupied by cations and anions
• Held together by electrostatic attraction
• Hard, brittle, high melting point
• Poor conductor of heat and electricity
CsCl ZnS CaF2
Covalent Crystals
• Lattice points occupied by atoms
• Held together by covalent bonds
• Hard, high melting point
• Poor conductor of heat and electricity
carbon
atoms
diamond
graphite
Metallic Crystals
• Lattice points occupied by metal atoms
• Held together by metallic bonds
• Soft to hard, low to high melting point
• Good conductors of heat and electricity
nucleus &
inner shell e-
mobile “sea”
of e-
Cross Section of a Metallic Crystal
Polymorphism
. Some elemental substance such as C
and S ,may exist in more than one
crystalline form and are said to be
allotropic, which is a special case of
polymorphism
. Polymorphism is the ability of a
substance to exist in more than one
crystal structure
Polymorphism is the ability of a substance to exist in more than one
crystal structure
Polymorphs: when two crystals have the same chemical composition
but different internal structure (molecular packing –molecular
conformation or / and inter or intra molecular
interactions)modifications or polymorphs or forms
Pseudo polymorphs : different crystal forms have molecules of the
same given substances and also contain molecules of solvent
incorporated into a unique structure (solvates or hydrates (water))
The most common example of polymorphism
carbon
atoms
High T and p
diamond graphite
Diamond is metastable and converts very slowly to graphite
Solid State : Polymorphs
Mono-component systems: Polymorphs
Multi-component systems
Cocrystal
. The simplest definition of a cocrystal is a crystalline structure made
up of two or more components in a definite stoichiometric ratio,
where each component is defined as either an atom, ion, or
molecule.
Principle of polymorphism
. When the change from one form to another is reversible, it is said to
be enantiotropic.
. When the transition takes place in one direction only—for example,
from a metastable to a stable form—the change is said to be
monotropic.
Solvates
. Pharmaceutical synthesis include purification and crystallization,
residual solvent can be trapped in the lattice.
This result in the formation of cocrystal or solvate.
. The presence of residual solvent may affect dramatically the
crystalline structure of the solid depending on the type of inter.
molecular forces that the solvent may have with crystalline solid
Polymorphism
Photochemical reactivity
Thermal stability
Filtration and drying characteristics
Dissolution rate
Melting point
Vapor pressure
Hardness
Optical, electrical magnetic
properties Bioavailability
Color Physical and chemical stability
IR spectra
NMR spectra
Solubility and melting point are very important in pharmaceutical
processes including dissolution and formulation.
Amorphous Solid
. An amorphous solid does not possess a well-defined arrangement and long-range
molecular order.
. Amorphous substances, as well as cubic crystal, are isotropic, that is, they exhibit
similar properties in all direction.
AMORPHOUS SOLIDS
Solids that don’t have a definite geometrical shape are known as Amorphous Solids.
1. In these solids particles are randomly arranged in three dimension.
2. They don’t have sharp melting points.
3. Amorphous solids are formed due to sudden cooling of liquid.
4. Amorphous solids melt over a wide range of temperature
Amorphous or crystalline & therapeutic
activity
. The crystalline from of the antibiotic novobiocin acid is poorly
absorbed and has no activity, where the amorphous form is readily
absorbed and therapeutically active, due to different dissolution rate.
Crystallization
General crystallization conditions
zSolvents –different polarities
zConcentration of the solutions (super saturated, saturated, diluted)
zCooling speed (quenching, slow)
zTemperature (room or lower than room temperature)
Polymorphism and Industry/ Pharmaceutical
Final Form
API
Granulation
Crystallization
Filtration
Drying
Drying
Compaction
Tableting
Milling
Drug Product
Bulk API
Stability
Polymorphism and Industry/
Pharmaceutical
. Fluoxetine HCl, the
active ingredient in the
antidepressant drug
Prozac.
. co crystal which will
have increased solubility
compared to the
crystalline form
Celecoxib
. CELECOXIB is a nonsteroidal anti-inflammatory drug
. However it was found that the higher bioavailability was shown by the amorphous state
. The downfall of the amorphous state was its stability.
. This was due to the structural relaxation.
. This was enhanced by mixing it with polymers like PVP, which helped in stabilizing the
amorphous system (Piyush Gupta et al. 2004, Piyush Gupta et al. 2005).
. A new solid state form was developed by Pharmacia
Furosemide
Two forms with significantly differing aqueous solubility and dissolution
rate
Oral bioavailability compromised
Giron lists >20 excipients that display polymorphism, including
– Lactose (anhydrous; also monohydrate)
– Aspartame (anhydrous; hydrate forms)
– Magnesium stearate (can affect lubrication of tablets)
Bioavailability
. The rate and extent to which the active ingredient or active moiety is
absorbed from a drug product and becomes available at the site of
action.
Bioequivalence
. The absence of a significant difference in the rate and extent to which
the active ingredient or active moiety in pharmaceutical equivalents
or pharmaceutical alternatives becomes available at the site of drug
action when administered at the same molar dose under similar
conditions in an appropriately designed study.
Carbamazepine
at least, six polymorphic white or almost white, crystalline
powder. It exhibits polymorphism. Practically insoluble in water
soluble in alcohol freely soluble in acetone and in dichlo-
romethane dissolves in dilute solutions of alkali hydroxides.
Protect from light.
CHLORPROPAMIDE
blood-glucose-lowering drug
AIDS drug ritonavir
Polymorphism and Industry/ Pharmaceutical
. Theobroma oil (cacao butter ) is a polymorphic natural fat.
. Theobroma oil can exist in 4 different polymorphic forms of
which only one is Stabile
1. Unstable gamma form melting at 18°C
2. Alpha form melting at 22°C
3. Beta prime form melting at 28°C
4. Stable beta form melting at 34.5°C
. This is important in the preparation of theobroma
suppositories.
. If the oil is heated to a point where it is completely liquified
(about 35 C), the crystals of the stable polymorph are
destroyed & the mass does not crystallize until it is cooled to
15 C.
. The crystals that form are unstable & the suppositories melt
at 24 C.
. Theobroma suppositories must be prepared below 33 C.
Polymorphism and Industry/ Pharmaceutical
Anhydrates together with salts form the majority of all drug formulations
About a half of all APIs used today are salts
Salts are stable and well soluble in polar solvents (first of all in water), because they contain ionic bond.
There is one more essential advantage of salts – their solubility is a function of pH. Since pH in the
gastrointestinal tract (GIT) vary between 1-7,5
atorvastatin calcium trihydrate
Each tablet contains Atorvastatin Calcium
Trihydrate equivalent to Atorvastatin 20 mg.
Phase Equilibria & The Phase Rule
Phase
diagram –
Water
Phase Equilibria & The Phase Rule: Definitions
. Phase Equilibrium: A stable phase structure with lowest free-energy (internal
energy) of a system, and also randomness or disorder of the atoms or molecules
(entropy).
. Any change in Temperature, Composition, and Pressure causes an increase in free
energy and away from Equilibrium thus forcing a move to another ‘state’
Phase Definition
. A phase is defined as any homogeneous and physically distinct part of a system which is
separated from other parts of the system by interfaces.
. A part of a system is homogeneous if it has identical physical properties and chemical
composition throughout the part.
A phase may be gas, liquid or solid.
A gas or a gaseous mixture is a single phase.
Totally miscible liquids constitute a single phase.
In an immiscible liquid system, each layer is counted as a separate phase.
Every solid constitutes a single phase except when a solid solution is formed.
A solid solution is considered as a single phase.
Each polymorphic form constitutes a separate phase.
• Examples
1. Liquid water, pieces of ice and water vapour are present together.
The number of phases is 3 as each form is a separate phase. Ice in the system is a single phase even
if it is present as a number of pieces.
2. Calcium carbonate undergoes thermal decomposition.
The chemical reaction is: CaCO (s) CaO(s) + CO (g)
3 2
Number of phases = 3 : This system consists of 2 solid phases, CaCO3 and CaO and one gaseous
phase, that of CO .
2
3. Ammonium chloride undergoes thermal decomposition. The chemical reaction is:
. NH4Cl(s) NH3 (g) + HCl (g) Number of phases = 2
. This system has two phases, one solid, NH Cl and one gaseous, a mixture of NH and HCl.
4 3
4. A solution of NaCl in water Number of phases = 1
Components
. The number of components of a system at equilibrium is the smallest
number of independently varying chemical constituents using which
the composition of each and every phase in the system can be
expressed.
• Examples
. Counting the number of components
1. The sulphur system is a one component system. All the phases,
monoclinic, rhombic, liquid and vapour – can be expressed in terms
of the single constituent – sulphur.
2. A mixture of ethanol and water is an example of a two component
system. We need both ethanol and water to express its
composition.
An example of a system in which a reaction occurs and an equilibrium is established is the
thermal decomposition of solid CaCO .
3
In this system, there are three distinct phases:
Solid CaCO3
Solid CaO
Gaseous CO2
Though there are 3 species present, the number of components is only two, because of the
equilibrium:
. CaCO (s) CaO(s) + CO (g)
3 2
. Any two of the three constituents may be chosen as the components.
. If CaO and CO are chosen, then the composition of the phase CaCO is expressed as one mole of
2 3
component CO plus one mole of component CaO.
2
. If, on the other hand, CaCO and CO were chosen, then the composition of the phase CaO would
3 2
be described as one mole of CaCO minus one mole of CO .
3 2
Degrees of freedom (or variance)
. The degrees of freedom or variance of a system is defined as the
minimum number of variables such as:
temperature
pressure
concentration
which must be fixed in order to define the system completely.
F = C P + 2
• Examples
1. A gaseous mixture of CO and N .
2 2
Three variables: pressure, temperature and composition are required to define this system.
This is, hence, a trivariant system.
2. A system having only liquid water has two degrees of freedom or is bivariant. Both
temperature and pressure need to be mentioned in order to define the system.
3. If to the system containing liquid water, pieces of ice are added and this system with 2
phases is allowed to come to equilibrium, then it is an univariant system.
Only one variable, either temperature or pressure need to be specified in order to define
the system.
If the pressure on the system is maintained at 1 atm, then the temperature of the system
gets automatically fixed at 0oC, the normal melting point of ice.
Phase Equilibria & The Phase Rule
. A phase diagram (Equilibrium Phase Diagram) summarizes the
conditions at which a substance exists as a solid, liquid, or gas.
. OR : It is a “map” of the information about the control of phase
structure of a particular material system.
. The relationships between temperature and the compositions and
the quantities of phases present at equilibrium are represented.
The phase rule
. J.W. Gibbs formulated the phase rule, which is a general relation
between the variance, F, the number of component, C, and the
number of phases P
, at equilibrium , for a system of any
composition:
. For a system in equilibrium F = C P + 2
The phase rule
. F : degree of freedom, the least number of intensive variable that
must be fixed (known) to describe the system completely
. Phase Rule relation to determine the least number of intensive
variable, that can be changed without changing the equilibrium state
of the system, or, alternately,
The least number required to define the state of the system, which is
called degree of freedom F.
. Intensive variable independent variable that do not depend on the
volume or the size, e.g.Temp., pressure
Phase Equilibria & The Phase Rule
Components of a system
. Independent chemical species which comprise the system:
These could be: Elements, Ions, Compounds
E.g. Au-Cu system : Components →Au, Cu
Ice-water system : Component →H O
2
Al O – Cr O system : Components →Al O , Cr O
2 3 2 3 2 3 2 3
. Component the smallest number of constituent by which the composition
of each phase in the system at equilibrium can be expressed in form of
chemical formula or equation
The number of phases in a system is denoted P
(a)A gas, or a gaseous mixture is a single phase. P=1
(b) For a solid system, an alloy of two metals is a two-phase system (P=2) if the metals
are immiscible, but a single-phase system (P=1) if they are miscible---a homogeneous
mixture of the two substances---is uniform on a molecular scale.
(c) For a liquid system, according to the solubility to decide whether a system consists of
one phase or of two.
For example, a solution of sodium chloride in water is a single phase.
A pair of liquids that are partially miscible or immiscible is a two-phase system(P=2)
Oil in water
A way of understanding the Gibbs Phase Rule:
The degrees of freedom can be thought of as the difference between what you (can) control and
what the system controls
F = C + 2 P
Degrees of Freedom = What you can control What the system controls
Can control the no. of
components added and P & T
System decided how many
phases to produce given the
conditions
. F : degree of freedom, the least number of intensive variable that must be fixed
(known) to describe the system completely
. Degree of freedom (or variance) F is the number of variables (T, p, and/or
composition) that can be changed independently without changing the phases of
the system
a) At the triple point:
P = 3 (solid, liquid, and gas)
C= 1 (water)
P + F = C + 2
F = 0 (no degree of freedom)
b) liquid-solid curve
P = 2
2+F = 1 + 2
F= 1
One variable (T or P) can be changed
c) Liquid
P =1
So F =2
Two variables (T and P) can be varied independently
and the system will remains a single phase
One-component systems
Phase diagram of water
Curve O-A
Vaporization
Condensation Critical point
218
Curve O -B
Melting
1
Freezing
Curve O -C
Sublimation
0.006
Deposition
=100
=0
O--Triple point
374
F = C P + 2
F = C P + 2
Phase Diagram of Carbon Dioxide
. Condensed system: System in which the vapor phase is ignored and only
the solid and/or liquid phases are considered.
Two component system
. For two component system F can be 3, (3D model is needed), e.g. T
, p and
concentration , usually we fix p = 1atm , the vapor phase is neglected, and F
is reduced to 2
. For three component system the pressure and temperature are fixed
Phenol water phase diagram
Two component system containing liquid phase
. Tie Line : bc line: The line at which the system at
equilibrium will separate into phases of constant
composition, termed ‘conjugate phases’
. Lever Rule: a way to calculate the proportions of each
phase present on a phase diagram in a two phase field
(at a given temperature and composition).
e.g. for point d (24%)
e.g. for point d (24%)
For every 10 g of liquid system
in equilibrium in point d
7.5 g phase A
2.5 g phase B water rich phase
contains water+ phenol(11%)
Example:
Mixed 24g phenol +76g water , T 50°C,
equilibrium
Phenol rich phase
75 g phase A 25 g phase B
contains Phenol (63%)+ water
11% phenol 63 % phenol
0.11× 75 g=8.25 g
phenol
0.63× 25 g=15.75 g
phenol
The Critical Solution Temperature: CST
. Is the maximum temperature at which
the 2-phase region exists (or upper
consolute temperature).
. In the case of the phenol-water system,
this is 66.8oC (point h)
. All combinations of phenol and water >
CST are completely miscible and yield 1-
phase liquid systems.
Systems Showing a Decrease in Miscibility with
Rise in Temperature
. A few mixtures, exhibit a lower critical
solution temperature (low CST), e.g.
triethylamine plus water. The miscibility
with in temperature.
Systems Showing Upper and Lower CSTs
The miscibility with temp.
a certain temperature miscibility
starts to again with further in
temperature.
Closed-phase diagram, i.e.
nicotine-water system.
Two component system containing solid
and liquid phase (Eutectic Mixtures)
B: thymol
A :salol
53%
B: thymol
A :salol
Eutectic mixture : Pharmaceutical Application
. EMLA® (lidocaine 2.5% and prilocaine 2.5%) Cream
. EMLA Cream (lidocaine 2.5% and prilocaine 2.5%) is an emulsion in which the oil
phase is a eutectic mixture of lidocaine and prilocaine in a ratio of 1:1 by weight.
This eutectic mixture has a melting point below room temperature and therefore
both local anesthetics exist as a liquid oil rather than as crystals
Three component system
Triangular Diagrams for three – component
systems
Shtaya
Topics that we have covered:
1. Binding Forces Between Molecules
2. Repulsive and Attractive Forces
3. The Gaseous State
The Ideal Gas Law
Liquefaction of Gases
Aerosols
4. Solids and the Crystalline State
Crystalline Solids
Polymorphism
Solvates
Amorphous Solids
5. Phase Equilibria and the Phase Rule
Phase Rule
Systems Containing One Component
Condensed System
Two-Component Systems Containing Liquid Phases
Two-Component Systems Containing Solid and Liquid Phases : Eutectic Mixtures
Rules Relating to Triangular Diagrams
Any Questions
Study Questions
Define the following terms:
[solid, liquid, gas, pure substance, compound, mixture, element, heterogeneous mixture, homogeneous mixture,
extensive properties, intensive properties, chemical properties, physical properties, density, color, texture, conductivity,
malleability, ductility, boiling point, melting point, flammability, corrosiveness, volatility, pounding, tearing, cutting,
dissolving, evaporating, fermenting, decomposing, Exothermic, endothermic, mass, density, gravity, adhesive force,
cohesive force, etc]
Respond to the following questions:
➢What is a mass, inertia, and how do these two variables affect the movement of material substance
➢What is gravity and how does it affect the movement of material substance
➢Give a descriptive account of the phases of matter with logical relevance to state of medicines as they are taken
for their respective therapeutical values
➢What is viscosity and its relation with fluids
➢What is surface tension and association with activities a substance material with surface area
➢Describe some key phase changes of materials substance when exposed to some environmental conditions of
change
➢How is a chemical change different from a physical change
Group work discussional questions:
➢ Give a detailed description Binding Forces Between Molecules
➢ Explain what is meant by Repulsive and Attractive Forces
➢ Explain with examples The Gaseous State of pharmaceutical material
➢ Explain with examples The solid State of pharmaceutical material
➢ Explain with examples The Crystalline State of pharmaceutical material
➢ Explain with examples The liquid State of pharmaceutical material
➢ Explain with examples The semi-solid State of pharmaceutical material
➢ Explain with examples The semi-solid State of pharmaceutical material
➢ Explain with examples The semi-liquid State of pharmaceutical materia

More Related Content

Similar to 1-2-PhysicalState of Matter.pdf

Techniques in Organic Chemistry
Techniques in Organic ChemistryTechniques in Organic Chemistry
Techniques in Organic Chemistry
Afael
 
Importance of Polymorphs in Pharma Industry by dr. amsavel
Importance of Polymorphs in Pharma Industry  by dr. amsavelImportance of Polymorphs in Pharma Industry  by dr. amsavel
Importance of Polymorphs in Pharma Industry by dr. amsavel
Dr. Amsavel A
 
polymorph.pptx
polymorph.pptxpolymorph.pptx
polymorph.pptx
Murad56
 
polymorph.pptx
polymorph.pptxpolymorph.pptx
polymorph.pptx
Murad56
 
Polymorphism
PolymorphismPolymorphism
Polymorphism
Mahendra G S
 
Liquid crystals
Liquid crystalsLiquid crystals
Liquid crystals
BANDHAN PANDA
 
Metastable polymorphism
Metastable polymorphismMetastable polymorphism
Metastable polymorphism
Prachi Joshi
 
Liquid Crystal and Liquid Crystal Polymer
Liquid Crystal and Liquid Crystal PolymerLiquid Crystal and Liquid Crystal Polymer
Liquid Crystal and Liquid Crystal Polymer
Saurav Ch. Sarma
 
Engineering Chemistry - LC slides - 20.ppt
Engineering Chemistry - LC slides - 20.pptEngineering Chemistry - LC slides - 20.ppt
Engineering Chemistry - LC slides - 20.ppt
happycocoman
 
State of matter and properties of matter (Part-7)(Solid-crystalline, Amorpho...
State of matter and properties  of matter (Part-7)(Solid-crystalline, Amorpho...State of matter and properties  of matter (Part-7)(Solid-crystalline, Amorpho...
State of matter and properties of matter (Part-7)(Solid-crystalline, Amorpho...
Ms. Pooja Bhandare
 
Physico-chemical Properties Affecting Drug Formulation.
Physico-chemical Properties Affecting Drug Formulation.Physico-chemical Properties Affecting Drug Formulation.
Physico-chemical Properties Affecting Drug Formulation.
Muavia Sarwar
 
AP Chemistry Chapter 13 Outline
AP Chemistry Chapter 13 OutlineAP Chemistry Chapter 13 Outline
AP Chemistry Chapter 13 Outline
Jane Hamze
 
Ch13 outline
Ch13 outlineCh13 outline
Ch13 outline
AP_Chem
 
liquid crystals and their applications
liquid crystals and their applicationsliquid crystals and their applications
liquid crystals and their applications
Minhas Azeem
 
Solid State Pharmaceutical.ppt
Solid State Pharmaceutical.pptSolid State Pharmaceutical.ppt
Solid State Pharmaceutical.ppt
CosmasZebua
 
2. PPT DOWNLOADED.ppt
2. PPT DOWNLOADED.ppt2. PPT DOWNLOADED.ppt
2. PPT DOWNLOADED.ppt
vaishalilikhar1
 
Ch 1 Matter in Our Surroundings Slide show 3.ppt
Ch 1 Matter in Our Surroundings Slide show 3.pptCh 1 Matter in Our Surroundings Slide show 3.ppt
Ch 1 Matter in Our Surroundings Slide show 3.ppt
RajveerKaushal1
 
Liquid crystals
Liquid crystalsLiquid crystals
Liquid crystals
G V S R PAVAN KUMAR
 
STRAND 1 MIXTURES ELEMENTS AND COMPOUNDS.pptx
STRAND 1 MIXTURES ELEMENTS AND COMPOUNDS.pptxSTRAND 1 MIXTURES ELEMENTS AND COMPOUNDS.pptx
STRAND 1 MIXTURES ELEMENTS AND COMPOUNDS.pptx
kimdan468
 
Jyothi
JyothiJyothi
Jyothi
jyothirmai17
 

Similar to 1-2-PhysicalState of Matter.pdf (20)

Techniques in Organic Chemistry
Techniques in Organic ChemistryTechniques in Organic Chemistry
Techniques in Organic Chemistry
 
Importance of Polymorphs in Pharma Industry by dr. amsavel
Importance of Polymorphs in Pharma Industry  by dr. amsavelImportance of Polymorphs in Pharma Industry  by dr. amsavel
Importance of Polymorphs in Pharma Industry by dr. amsavel
 
polymorph.pptx
polymorph.pptxpolymorph.pptx
polymorph.pptx
 
polymorph.pptx
polymorph.pptxpolymorph.pptx
polymorph.pptx
 
Polymorphism
PolymorphismPolymorphism
Polymorphism
 
Liquid crystals
Liquid crystalsLiquid crystals
Liquid crystals
 
Metastable polymorphism
Metastable polymorphismMetastable polymorphism
Metastable polymorphism
 
Liquid Crystal and Liquid Crystal Polymer
Liquid Crystal and Liquid Crystal PolymerLiquid Crystal and Liquid Crystal Polymer
Liquid Crystal and Liquid Crystal Polymer
 
Engineering Chemistry - LC slides - 20.ppt
Engineering Chemistry - LC slides - 20.pptEngineering Chemistry - LC slides - 20.ppt
Engineering Chemistry - LC slides - 20.ppt
 
State of matter and properties of matter (Part-7)(Solid-crystalline, Amorpho...
State of matter and properties  of matter (Part-7)(Solid-crystalline, Amorpho...State of matter and properties  of matter (Part-7)(Solid-crystalline, Amorpho...
State of matter and properties of matter (Part-7)(Solid-crystalline, Amorpho...
 
Physico-chemical Properties Affecting Drug Formulation.
Physico-chemical Properties Affecting Drug Formulation.Physico-chemical Properties Affecting Drug Formulation.
Physico-chemical Properties Affecting Drug Formulation.
 
AP Chemistry Chapter 13 Outline
AP Chemistry Chapter 13 OutlineAP Chemistry Chapter 13 Outline
AP Chemistry Chapter 13 Outline
 
Ch13 outline
Ch13 outlineCh13 outline
Ch13 outline
 
liquid crystals and their applications
liquid crystals and their applicationsliquid crystals and their applications
liquid crystals and their applications
 
Solid State Pharmaceutical.ppt
Solid State Pharmaceutical.pptSolid State Pharmaceutical.ppt
Solid State Pharmaceutical.ppt
 
2. PPT DOWNLOADED.ppt
2. PPT DOWNLOADED.ppt2. PPT DOWNLOADED.ppt
2. PPT DOWNLOADED.ppt
 
Ch 1 Matter in Our Surroundings Slide show 3.ppt
Ch 1 Matter in Our Surroundings Slide show 3.pptCh 1 Matter in Our Surroundings Slide show 3.ppt
Ch 1 Matter in Our Surroundings Slide show 3.ppt
 
Liquid crystals
Liquid crystalsLiquid crystals
Liquid crystals
 
STRAND 1 MIXTURES ELEMENTS AND COMPOUNDS.pptx
STRAND 1 MIXTURES ELEMENTS AND COMPOUNDS.pptxSTRAND 1 MIXTURES ELEMENTS AND COMPOUNDS.pptx
STRAND 1 MIXTURES ELEMENTS AND COMPOUNDS.pptx
 
Jyothi
JyothiJyothi
Jyothi
 

More from MuungoLungwani

1-1-Computing and Pharmaceutical Numeracy.pdf
1-1-Computing and Pharmaceutical Numeracy.pdf1-1-Computing and Pharmaceutical Numeracy.pdf
1-1-Computing and Pharmaceutical Numeracy.pdf
MuungoLungwani
 
2-4-PhaseEquilibriumGeneric.pdf
2-4-PhaseEquilibriumGeneric.pdf2-4-PhaseEquilibriumGeneric.pdf
2-4-PhaseEquilibriumGeneric.pdf
MuungoLungwani
 
1-3-Physical Properties of Pharmaceutical-Related Materials.pdf
1-3-Physical Properties of Pharmaceutical-Related Materials.pdf1-3-Physical Properties of Pharmaceutical-Related Materials.pdf
1-3-Physical Properties of Pharmaceutical-Related Materials.pdf
MuungoLungwani
 
2-5-PhaseEquilibriaPharmacy.pdf
2-5-PhaseEquilibriaPharmacy.pdf2-5-PhaseEquilibriaPharmacy.pdf
2-5-PhaseEquilibriaPharmacy.pdf
MuungoLungwani
 
PMY 6110_1-4-Pharmaceutical Care Plan.pdf
PMY 6110_1-4-Pharmaceutical Care Plan.pdfPMY 6110_1-4-Pharmaceutical Care Plan.pdf
PMY 6110_1-4-Pharmaceutical Care Plan.pdf
MuungoLungwani
 
PMY 6110_1-5-Illustration of Bedridden Patient Management.pdf
PMY 6110_1-5-Illustration of Bedridden Patient Management.pdfPMY 6110_1-5-Illustration of Bedridden Patient Management.pdf
PMY 6110_1-5-Illustration of Bedridden Patient Management.pdf
MuungoLungwani
 
PMY 6110_1-1-General In - Copy.pdf
PMY 6110_1-1-General In - Copy.pdfPMY 6110_1-1-General In - Copy.pdf
PMY 6110_1-1-General In - Copy.pdf
MuungoLungwani
 
PMY 6110_1-7-Principles of Nutraceutical Care.pdf
PMY 6110_1-7-Principles of Nutraceutical Care.pdfPMY 6110_1-7-Principles of Nutraceutical Care.pdf
PMY 6110_1-7-Principles of Nutraceutical Care.pdf
MuungoLungwani
 
PMY 6110_1-6-Pharmaceutical Care Evaluation.pdf
PMY 6110_1-6-Pharmaceutical Care Evaluation.pdfPMY 6110_1-6-Pharmaceutical Care Evaluation.pdf
PMY 6110_1-6-Pharmaceutical Care Evaluation.pdf
MuungoLungwani
 
PMY 6110_1-1-General Information on Clinical Pharmacy.pdf
PMY 6110_1-1-General Information on Clinical Pharmacy.pdfPMY 6110_1-1-General Information on Clinical Pharmacy.pdf
PMY 6110_1-1-General Information on Clinical Pharmacy.pdf
MuungoLungwani
 
PMY 6110_1-3-Therapeuti - Copy.pdf
PMY 6110_1-3-Therapeuti - Copy.pdfPMY 6110_1-3-Therapeuti - Copy.pdf
PMY 6110_1-3-Therapeuti - Copy.pdf
MuungoLungwani
 
PMY 6110_2-2-Gastrointestinal Diseases.pdf
PMY 6110_2-2-Gastrointestinal Diseases.pdfPMY 6110_2-2-Gastrointestinal Diseases.pdf
PMY 6110_2-2-Gastrointestinal Diseases.pdf
MuungoLungwani
 
PMY 6110_1-4-Pharmaceutical Care.pdf
PMY 6110_1-4-Pharmaceutical Care.pdfPMY 6110_1-4-Pharmaceutical Care.pdf
PMY 6110_1-4-Pharmaceutical Care.pdf
MuungoLungwani
 
PMY 6110_1-3-Therapeutical Process Assessment.pdf
PMY 6110_1-3-Therapeutical Process Assessment.pdfPMY 6110_1-3-Therapeutical Process Assessment.pdf
PMY 6110_1-3-Therapeutical Process Assessment.pdf
MuungoLungwani
 
PMY 6110_1-2-Principles of Pharmaceutical Care 1.pdf
PMY 6110_1-2-Principles of Pharmaceutical Care 1.pdfPMY 6110_1-2-Principles of Pharmaceutical Care 1.pdf
PMY 6110_1-2-Principles of Pharmaceutical Care 1.pdf
MuungoLungwani
 
PMY 6110_1-2-Principles - Copy.pdf
PMY 6110_1-2-Principles - Copy.pdfPMY 6110_1-2-Principles - Copy.pdf
PMY 6110_1-2-Principles - Copy.pdf
MuungoLungwani
 
0-Curriculum - 2010-Date MCPharmUNZA - FinalCopy.pdf
0-Curriculum - 2010-Date MCPharmUNZA - FinalCopy.pdf0-Curriculum - 2010-Date MCPharmUNZA - FinalCopy.pdf
0-Curriculum - 2010-Date MCPharmUNZA - FinalCopy.pdf
MuungoLungwani
 
PMY 6120_1-1-Preformulation Characteristics of Pharmaceutical Product Systems...
PMY 6120_1-1-Preformulation Characteristics of Pharmaceutical Product Systems...PMY 6120_1-1-Preformulation Characteristics of Pharmaceutical Product Systems...
PMY 6120_1-1-Preformulation Characteristics of Pharmaceutical Product Systems...
MuungoLungwani
 
PMY 6120_1-2-Pharmaceutical Formulation Systems_Compound and Dispensing Proce...
PMY 6120_1-2-Pharmaceutical Formulation Systems_Compound and Dispensing Proce...PMY 6120_1-2-Pharmaceutical Formulation Systems_Compound and Dispensing Proce...
PMY 6120_1-2-Pharmaceutical Formulation Systems_Compound and Dispensing Proce...
MuungoLungwani
 
1-Course MaterialOutline PMY 5021 - 2017.pdf
1-Course MaterialOutline PMY 5021  - 2017.pdf1-Course MaterialOutline PMY 5021  - 2017.pdf
1-Course MaterialOutline PMY 5021 - 2017.pdf
MuungoLungwani
 

More from MuungoLungwani (20)

1-1-Computing and Pharmaceutical Numeracy.pdf
1-1-Computing and Pharmaceutical Numeracy.pdf1-1-Computing and Pharmaceutical Numeracy.pdf
1-1-Computing and Pharmaceutical Numeracy.pdf
 
2-4-PhaseEquilibriumGeneric.pdf
2-4-PhaseEquilibriumGeneric.pdf2-4-PhaseEquilibriumGeneric.pdf
2-4-PhaseEquilibriumGeneric.pdf
 
1-3-Physical Properties of Pharmaceutical-Related Materials.pdf
1-3-Physical Properties of Pharmaceutical-Related Materials.pdf1-3-Physical Properties of Pharmaceutical-Related Materials.pdf
1-3-Physical Properties of Pharmaceutical-Related Materials.pdf
 
2-5-PhaseEquilibriaPharmacy.pdf
2-5-PhaseEquilibriaPharmacy.pdf2-5-PhaseEquilibriaPharmacy.pdf
2-5-PhaseEquilibriaPharmacy.pdf
 
PMY 6110_1-4-Pharmaceutical Care Plan.pdf
PMY 6110_1-4-Pharmaceutical Care Plan.pdfPMY 6110_1-4-Pharmaceutical Care Plan.pdf
PMY 6110_1-4-Pharmaceutical Care Plan.pdf
 
PMY 6110_1-5-Illustration of Bedridden Patient Management.pdf
PMY 6110_1-5-Illustration of Bedridden Patient Management.pdfPMY 6110_1-5-Illustration of Bedridden Patient Management.pdf
PMY 6110_1-5-Illustration of Bedridden Patient Management.pdf
 
PMY 6110_1-1-General In - Copy.pdf
PMY 6110_1-1-General In - Copy.pdfPMY 6110_1-1-General In - Copy.pdf
PMY 6110_1-1-General In - Copy.pdf
 
PMY 6110_1-7-Principles of Nutraceutical Care.pdf
PMY 6110_1-7-Principles of Nutraceutical Care.pdfPMY 6110_1-7-Principles of Nutraceutical Care.pdf
PMY 6110_1-7-Principles of Nutraceutical Care.pdf
 
PMY 6110_1-6-Pharmaceutical Care Evaluation.pdf
PMY 6110_1-6-Pharmaceutical Care Evaluation.pdfPMY 6110_1-6-Pharmaceutical Care Evaluation.pdf
PMY 6110_1-6-Pharmaceutical Care Evaluation.pdf
 
PMY 6110_1-1-General Information on Clinical Pharmacy.pdf
PMY 6110_1-1-General Information on Clinical Pharmacy.pdfPMY 6110_1-1-General Information on Clinical Pharmacy.pdf
PMY 6110_1-1-General Information on Clinical Pharmacy.pdf
 
PMY 6110_1-3-Therapeuti - Copy.pdf
PMY 6110_1-3-Therapeuti - Copy.pdfPMY 6110_1-3-Therapeuti - Copy.pdf
PMY 6110_1-3-Therapeuti - Copy.pdf
 
PMY 6110_2-2-Gastrointestinal Diseases.pdf
PMY 6110_2-2-Gastrointestinal Diseases.pdfPMY 6110_2-2-Gastrointestinal Diseases.pdf
PMY 6110_2-2-Gastrointestinal Diseases.pdf
 
PMY 6110_1-4-Pharmaceutical Care.pdf
PMY 6110_1-4-Pharmaceutical Care.pdfPMY 6110_1-4-Pharmaceutical Care.pdf
PMY 6110_1-4-Pharmaceutical Care.pdf
 
PMY 6110_1-3-Therapeutical Process Assessment.pdf
PMY 6110_1-3-Therapeutical Process Assessment.pdfPMY 6110_1-3-Therapeutical Process Assessment.pdf
PMY 6110_1-3-Therapeutical Process Assessment.pdf
 
PMY 6110_1-2-Principles of Pharmaceutical Care 1.pdf
PMY 6110_1-2-Principles of Pharmaceutical Care 1.pdfPMY 6110_1-2-Principles of Pharmaceutical Care 1.pdf
PMY 6110_1-2-Principles of Pharmaceutical Care 1.pdf
 
PMY 6110_1-2-Principles - Copy.pdf
PMY 6110_1-2-Principles - Copy.pdfPMY 6110_1-2-Principles - Copy.pdf
PMY 6110_1-2-Principles - Copy.pdf
 
0-Curriculum - 2010-Date MCPharmUNZA - FinalCopy.pdf
0-Curriculum - 2010-Date MCPharmUNZA - FinalCopy.pdf0-Curriculum - 2010-Date MCPharmUNZA - FinalCopy.pdf
0-Curriculum - 2010-Date MCPharmUNZA - FinalCopy.pdf
 
PMY 6120_1-1-Preformulation Characteristics of Pharmaceutical Product Systems...
PMY 6120_1-1-Preformulation Characteristics of Pharmaceutical Product Systems...PMY 6120_1-1-Preformulation Characteristics of Pharmaceutical Product Systems...
PMY 6120_1-1-Preformulation Characteristics of Pharmaceutical Product Systems...
 
PMY 6120_1-2-Pharmaceutical Formulation Systems_Compound and Dispensing Proce...
PMY 6120_1-2-Pharmaceutical Formulation Systems_Compound and Dispensing Proce...PMY 6120_1-2-Pharmaceutical Formulation Systems_Compound and Dispensing Proce...
PMY 6120_1-2-Pharmaceutical Formulation Systems_Compound and Dispensing Proce...
 
1-Course MaterialOutline PMY 5021 - 2017.pdf
1-Course MaterialOutline PMY 5021  - 2017.pdf1-Course MaterialOutline PMY 5021  - 2017.pdf
1-Course MaterialOutline PMY 5021 - 2017.pdf
 

Recently uploaded

Cell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune DiseaseCell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune Disease
Health Advances
 
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptxEar and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
rishi2789
 
THERAPEUTIC ANTISENSE MOLECULES .pptx
THERAPEUTIC ANTISENSE MOLECULES    .pptxTHERAPEUTIC ANTISENSE MOLECULES    .pptx
THERAPEUTIC ANTISENSE MOLECULES .pptx
70KRISHPATEL
 
Cardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdfCardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdf
shivalingatalekar1
 
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdfCHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
rishi2789
 
Top-Vitamin-Supplement-Brands-in-India List
Top-Vitamin-Supplement-Brands-in-India ListTop-Vitamin-Supplement-Brands-in-India List
Top-Vitamin-Supplement-Brands-in-India List
SwisschemDerma
 
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...
Donc Test
 
Best Ayurvedic medicine for Gas and Indigestion
Best Ayurvedic medicine for Gas and IndigestionBest Ayurvedic medicine for Gas and Indigestion
Best Ayurvedic medicine for Gas and Indigestion
Swastik Ayurveda
 
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
rishi2789
 
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.GawadHemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
NephroTube - Dr.Gawad
 
Identification and nursing management of congenital malformations .pptx
Identification and nursing management of congenital malformations .pptxIdentification and nursing management of congenital malformations .pptx
Identification and nursing management of congenital malformations .pptx
MGM SCHOOL/COLLEGE OF NURSING
 
Dehradun #ℂall #gIRLS Oyo Hotel 8107221448 #ℂall #gIRL in Dehradun
Dehradun #ℂall #gIRLS Oyo Hotel 8107221448 #ℂall #gIRL in DehradunDehradun #ℂall #gIRLS Oyo Hotel 8107221448 #ℂall #gIRL in Dehradun
Dehradun #ℂall #gIRLS Oyo Hotel 8107221448 #ℂall #gIRL in Dehradun
chandankumarsmartiso
 
Tests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptxTests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptx
taiba qazi
 
Top 10 Best Ayurvedic Kidney Stone Syrups in India
Top 10 Best Ayurvedic Kidney Stone Syrups in IndiaTop 10 Best Ayurvedic Kidney Stone Syrups in India
Top 10 Best Ayurvedic Kidney Stone Syrups in India
Swastik Ayurveda
 
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptxVestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotesPromoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
PsychoTech Services
 
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
Integrating Ayurveda into Parkinson’s Management: A Holistic ApproachIntegrating Ayurveda into Parkinson’s Management: A Holistic Approach
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
Ayurveda ForAll
 
Adhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.comAdhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.com
reignlana06
 
Light House Retreats: Plant Medicine Retreat Europe
Light House Retreats: Plant Medicine Retreat EuropeLight House Retreats: Plant Medicine Retreat Europe
Light House Retreats: Plant Medicine Retreat Europe
Lighthouse Retreat
 

Recently uploaded (20)

Cell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune DiseaseCell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune Disease
 
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptxEar and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
 
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
 
THERAPEUTIC ANTISENSE MOLECULES .pptx
THERAPEUTIC ANTISENSE MOLECULES    .pptxTHERAPEUTIC ANTISENSE MOLECULES    .pptx
THERAPEUTIC ANTISENSE MOLECULES .pptx
 
Cardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdfCardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdf
 
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdfCHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
 
Top-Vitamin-Supplement-Brands-in-India List
Top-Vitamin-Supplement-Brands-in-India ListTop-Vitamin-Supplement-Brands-in-India List
Top-Vitamin-Supplement-Brands-in-India List
 
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...
 
Best Ayurvedic medicine for Gas and Indigestion
Best Ayurvedic medicine for Gas and IndigestionBest Ayurvedic medicine for Gas and Indigestion
Best Ayurvedic medicine for Gas and Indigestion
 
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
 
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.GawadHemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
 
Identification and nursing management of congenital malformations .pptx
Identification and nursing management of congenital malformations .pptxIdentification and nursing management of congenital malformations .pptx
Identification and nursing management of congenital malformations .pptx
 
Dehradun #ℂall #gIRLS Oyo Hotel 8107221448 #ℂall #gIRL in Dehradun
Dehradun #ℂall #gIRLS Oyo Hotel 8107221448 #ℂall #gIRL in DehradunDehradun #ℂall #gIRLS Oyo Hotel 8107221448 #ℂall #gIRL in Dehradun
Dehradun #ℂall #gIRLS Oyo Hotel 8107221448 #ℂall #gIRL in Dehradun
 
Tests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptxTests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptx
 
Top 10 Best Ayurvedic Kidney Stone Syrups in India
Top 10 Best Ayurvedic Kidney Stone Syrups in IndiaTop 10 Best Ayurvedic Kidney Stone Syrups in India
Top 10 Best Ayurvedic Kidney Stone Syrups in India
 
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptxVestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
 
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotesPromoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
 
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
Integrating Ayurveda into Parkinson’s Management: A Holistic ApproachIntegrating Ayurveda into Parkinson’s Management: A Holistic Approach
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
 
Adhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.comAdhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.com
 
Light House Retreats: Plant Medicine Retreat Europe
Light House Retreats: Plant Medicine Retreat EuropeLight House Retreats: Plant Medicine Retreat Europe
Light House Retreats: Plant Medicine Retreat Europe
 

1-2-PhysicalState of Matter.pdf

  • 2. States of Matter . Binding Forces Between Molecules . Solids and the Crystalline State . Phase Equilibria and the Phase Rule
  • 3. Objectives of the lecture After completion of this chapter, the students should be able to: Describe the solid state , crystallinity, solvates and polymorphism Understand phase equilibria and phase transitions between the three main states of matter Understand the phase rule and its application to different systems containing multiple components.
  • 4. Comparison of Gases, Liquids and Solids . Gases are compressible fluids. Their molecules are widely separated. . Liquids are relatively incompressible fluids. Their molecules are more tightly packed. . Solids are nearly incompressible and rigid. Their molecules or ions are in close contact and do not move. In order for molecules to exist in aggregates in gases, liquids and solids Intermolecular forces must exist
  • 5.
  • 6. Repulsive and Attractive Forces . As two atoms or molecules are brought closer together, the opposite charges and binding forces in the two molecules are closer together than the similar charges and forces, causing the molecules to attract one another. . The negatively charged electron clouds of molecules largely govern the balance (equilibrium) forces between the two molecules
  • 7. Ideal Gas Equation 1 V Boyle’s law: P a (at constant n and T) Charles’ law: V a T (at constant n and P) Avogadro’s law: V a n (at constant P and T) P V P V R is the gas constant 1 1 2 2 PV = nRT = T T2 1
  • 8. Gaseous state . The conditions 0 0C and 1 atm are called standard temperature and pressure (STP). . Experiments show that at STP, 1 mole of an ideal gas occupies 22.414 L. PV = nRT (1 atm)(22.414L) PV nT (1 mol)(273.15 K) = R = R = 0.082057 L • atm / (mol • K)
  • 9. Gaseous state What is the volume (in liters) occupied by 49.8 g of HCl at STP? T = 0 0C = 273.15 K 1 atm ≈ 760.001 mm-Hg P = 1 atm PV = nRT nRT 1 mol HCl n = 49.8 g x = 1.37 mol 36.45 g HCl V = P L•atm mol•K 1.37 mol x 0.0821 x 273.15 K V = 1 atm V = 30.7 L 9
  • 10. Gaseous state P V P V 2 2 1 1 = T2 T1
  • 11. Liquefaction of Gases . The critical temperature (T ) is the temperature above which the gas cannot be c made to liquefy, OR is the temperature above which the liquid cannot longer exist . The critical pressure (P ) is the minimum pressure required to liquefy a gas at its c critical temperature. . critical temperature (T ) of water is 374°C, or 647 K, and its critical pressure is c 218 atm,
  • 12.
  • 13. SOLIDS & CRYSTALLINE STATE Pharmaceutical Drugs: more than 80% are solid formulations
  • 14. Solids and the crystalline state . A crystalline solid possesses rigid and long-range order. . In a crystalline solid, atoms, molecules or ions occupy specific (predictable) positions. . An amorphous solid does not possess a well-defined arrangement and long-range molecular order.
  • 16. A unit cell is the basic repeating structural unit of a crystalline solid. lattice point At lattice points: • Atoms • Molecules • Ions Unit Cell Unit cells in 3 dimensions
  • 17. The crystal lattice of sodium chloride NaCl Cl Na
  • 18. Crystal forms The various crystal forms are divide to basic 7 unit according to its symmetry iodoform urea NaCl iodine Be Al (SiO ) 3 2 3 6 sucrose Boric acid
  • 19. Types of Crystals Ionic Crystals • Lattice points occupied by cations and anions • Held together by electrostatic attraction • Hard, brittle, high melting point • Poor conductor of heat and electricity CsCl ZnS CaF2
  • 20. Covalent Crystals • Lattice points occupied by atoms • Held together by covalent bonds • Hard, high melting point • Poor conductor of heat and electricity carbon atoms diamond graphite
  • 21. Metallic Crystals • Lattice points occupied by metal atoms • Held together by metallic bonds • Soft to hard, low to high melting point • Good conductors of heat and electricity nucleus & inner shell e- mobile “sea” of e- Cross Section of a Metallic Crystal
  • 22. Polymorphism . Some elemental substance such as C and S ,may exist in more than one crystalline form and are said to be allotropic, which is a special case of polymorphism . Polymorphism is the ability of a substance to exist in more than one crystal structure
  • 23. Polymorphism is the ability of a substance to exist in more than one crystal structure Polymorphs: when two crystals have the same chemical composition but different internal structure (molecular packing –molecular conformation or / and inter or intra molecular interactions)modifications or polymorphs or forms Pseudo polymorphs : different crystal forms have molecules of the same given substances and also contain molecules of solvent incorporated into a unique structure (solvates or hydrates (water))
  • 24. The most common example of polymorphism carbon atoms High T and p diamond graphite Diamond is metastable and converts very slowly to graphite
  • 25. Solid State : Polymorphs Mono-component systems: Polymorphs Multi-component systems
  • 26.
  • 27. Cocrystal . The simplest definition of a cocrystal is a crystalline structure made up of two or more components in a definite stoichiometric ratio, where each component is defined as either an atom, ion, or molecule.
  • 28. Principle of polymorphism . When the change from one form to another is reversible, it is said to be enantiotropic. . When the transition takes place in one direction only—for example, from a metastable to a stable form—the change is said to be monotropic.
  • 29. Solvates . Pharmaceutical synthesis include purification and crystallization, residual solvent can be trapped in the lattice. This result in the formation of cocrystal or solvate. . The presence of residual solvent may affect dramatically the crystalline structure of the solid depending on the type of inter. molecular forces that the solvent may have with crystalline solid
  • 30. Polymorphism Photochemical reactivity Thermal stability Filtration and drying characteristics Dissolution rate Melting point Vapor pressure Hardness Optical, electrical magnetic properties Bioavailability Color Physical and chemical stability IR spectra NMR spectra Solubility and melting point are very important in pharmaceutical processes including dissolution and formulation.
  • 31. Amorphous Solid . An amorphous solid does not possess a well-defined arrangement and long-range molecular order. . Amorphous substances, as well as cubic crystal, are isotropic, that is, they exhibit similar properties in all direction. AMORPHOUS SOLIDS Solids that don’t have a definite geometrical shape are known as Amorphous Solids. 1. In these solids particles are randomly arranged in three dimension. 2. They don’t have sharp melting points. 3. Amorphous solids are formed due to sudden cooling of liquid. 4. Amorphous solids melt over a wide range of temperature
  • 32. Amorphous or crystalline & therapeutic activity . The crystalline from of the antibiotic novobiocin acid is poorly absorbed and has no activity, where the amorphous form is readily absorbed and therapeutically active, due to different dissolution rate.
  • 33. Crystallization General crystallization conditions zSolvents –different polarities zConcentration of the solutions (super saturated, saturated, diluted) zCooling speed (quenching, slow) zTemperature (room or lower than room temperature)
  • 34. Polymorphism and Industry/ Pharmaceutical Final Form API Granulation Crystallization Filtration Drying Drying Compaction Tableting Milling Drug Product Bulk API Stability
  • 35. Polymorphism and Industry/ Pharmaceutical . Fluoxetine HCl, the active ingredient in the antidepressant drug Prozac. . co crystal which will have increased solubility compared to the crystalline form
  • 36. Celecoxib . CELECOXIB is a nonsteroidal anti-inflammatory drug . However it was found that the higher bioavailability was shown by the amorphous state . The downfall of the amorphous state was its stability. . This was due to the structural relaxation. . This was enhanced by mixing it with polymers like PVP, which helped in stabilizing the amorphous system (Piyush Gupta et al. 2004, Piyush Gupta et al. 2005). . A new solid state form was developed by Pharmacia
  • 37. Furosemide Two forms with significantly differing aqueous solubility and dissolution rate Oral bioavailability compromised Giron lists >20 excipients that display polymorphism, including – Lactose (anhydrous; also monohydrate) – Aspartame (anhydrous; hydrate forms) – Magnesium stearate (can affect lubrication of tablets)
  • 38. Bioavailability . The rate and extent to which the active ingredient or active moiety is absorbed from a drug product and becomes available at the site of action.
  • 39.
  • 40.
  • 41. Bioequivalence . The absence of a significant difference in the rate and extent to which the active ingredient or active moiety in pharmaceutical equivalents or pharmaceutical alternatives becomes available at the site of drug action when administered at the same molar dose under similar conditions in an appropriately designed study.
  • 42.
  • 44. at least, six polymorphic white or almost white, crystalline powder. It exhibits polymorphism. Practically insoluble in water soluble in alcohol freely soluble in acetone and in dichlo- romethane dissolves in dilute solutions of alkali hydroxides. Protect from light. CHLORPROPAMIDE blood-glucose-lowering drug
  • 46. Polymorphism and Industry/ Pharmaceutical . Theobroma oil (cacao butter ) is a polymorphic natural fat. . Theobroma oil can exist in 4 different polymorphic forms of which only one is Stabile 1. Unstable gamma form melting at 18°C 2. Alpha form melting at 22°C 3. Beta prime form melting at 28°C 4. Stable beta form melting at 34.5°C . This is important in the preparation of theobroma suppositories. . If the oil is heated to a point where it is completely liquified (about 35 C), the crystals of the stable polymorph are destroyed & the mass does not crystallize until it is cooled to 15 C. . The crystals that form are unstable & the suppositories melt at 24 C. . Theobroma suppositories must be prepared below 33 C.
  • 47. Polymorphism and Industry/ Pharmaceutical Anhydrates together with salts form the majority of all drug formulations About a half of all APIs used today are salts Salts are stable and well soluble in polar solvents (first of all in water), because they contain ionic bond. There is one more essential advantage of salts – their solubility is a function of pH. Since pH in the gastrointestinal tract (GIT) vary between 1-7,5 atorvastatin calcium trihydrate Each tablet contains Atorvastatin Calcium Trihydrate equivalent to Atorvastatin 20 mg.
  • 48. Phase Equilibria & The Phase Rule
  • 50. Phase Equilibria & The Phase Rule: Definitions . Phase Equilibrium: A stable phase structure with lowest free-energy (internal energy) of a system, and also randomness or disorder of the atoms or molecules (entropy). . Any change in Temperature, Composition, and Pressure causes an increase in free energy and away from Equilibrium thus forcing a move to another ‘state’
  • 51. Phase Definition . A phase is defined as any homogeneous and physically distinct part of a system which is separated from other parts of the system by interfaces. . A part of a system is homogeneous if it has identical physical properties and chemical composition throughout the part. A phase may be gas, liquid or solid. A gas or a gaseous mixture is a single phase. Totally miscible liquids constitute a single phase. In an immiscible liquid system, each layer is counted as a separate phase. Every solid constitutes a single phase except when a solid solution is formed. A solid solution is considered as a single phase. Each polymorphic form constitutes a separate phase.
  • 52. • Examples 1. Liquid water, pieces of ice and water vapour are present together. The number of phases is 3 as each form is a separate phase. Ice in the system is a single phase even if it is present as a number of pieces. 2. Calcium carbonate undergoes thermal decomposition. The chemical reaction is: CaCO (s) CaO(s) + CO (g) 3 2 Number of phases = 3 : This system consists of 2 solid phases, CaCO3 and CaO and one gaseous phase, that of CO . 2 3. Ammonium chloride undergoes thermal decomposition. The chemical reaction is: . NH4Cl(s) NH3 (g) + HCl (g) Number of phases = 2 . This system has two phases, one solid, NH Cl and one gaseous, a mixture of NH and HCl. 4 3 4. A solution of NaCl in water Number of phases = 1
  • 53. Components . The number of components of a system at equilibrium is the smallest number of independently varying chemical constituents using which the composition of each and every phase in the system can be expressed.
  • 54. • Examples . Counting the number of components 1. The sulphur system is a one component system. All the phases, monoclinic, rhombic, liquid and vapour – can be expressed in terms of the single constituent – sulphur. 2. A mixture of ethanol and water is an example of a two component system. We need both ethanol and water to express its composition.
  • 55. An example of a system in which a reaction occurs and an equilibrium is established is the thermal decomposition of solid CaCO . 3 In this system, there are three distinct phases: Solid CaCO3 Solid CaO Gaseous CO2 Though there are 3 species present, the number of components is only two, because of the equilibrium: . CaCO (s) CaO(s) + CO (g) 3 2 . Any two of the three constituents may be chosen as the components. . If CaO and CO are chosen, then the composition of the phase CaCO is expressed as one mole of 2 3 component CO plus one mole of component CaO. 2 . If, on the other hand, CaCO and CO were chosen, then the composition of the phase CaO would 3 2 be described as one mole of CaCO minus one mole of CO . 3 2
  • 56. Degrees of freedom (or variance) . The degrees of freedom or variance of a system is defined as the minimum number of variables such as: temperature pressure concentration which must be fixed in order to define the system completely. F = C P + 2
  • 57. • Examples 1. A gaseous mixture of CO and N . 2 2 Three variables: pressure, temperature and composition are required to define this system. This is, hence, a trivariant system. 2. A system having only liquid water has two degrees of freedom or is bivariant. Both temperature and pressure need to be mentioned in order to define the system. 3. If to the system containing liquid water, pieces of ice are added and this system with 2 phases is allowed to come to equilibrium, then it is an univariant system. Only one variable, either temperature or pressure need to be specified in order to define the system. If the pressure on the system is maintained at 1 atm, then the temperature of the system gets automatically fixed at 0oC, the normal melting point of ice.
  • 58. Phase Equilibria & The Phase Rule . A phase diagram (Equilibrium Phase Diagram) summarizes the conditions at which a substance exists as a solid, liquid, or gas. . OR : It is a “map” of the information about the control of phase structure of a particular material system. . The relationships between temperature and the compositions and the quantities of phases present at equilibrium are represented.
  • 59. The phase rule . J.W. Gibbs formulated the phase rule, which is a general relation between the variance, F, the number of component, C, and the number of phases P , at equilibrium , for a system of any composition: . For a system in equilibrium F = C P + 2 The phase rule . F : degree of freedom, the least number of intensive variable that must be fixed (known) to describe the system completely
  • 60. . Phase Rule relation to determine the least number of intensive variable, that can be changed without changing the equilibrium state of the system, or, alternately, The least number required to define the state of the system, which is called degree of freedom F. . Intensive variable independent variable that do not depend on the volume or the size, e.g.Temp., pressure
  • 61. Phase Equilibria & The Phase Rule Components of a system . Independent chemical species which comprise the system: These could be: Elements, Ions, Compounds E.g. Au-Cu system : Components →Au, Cu Ice-water system : Component →H O 2 Al O – Cr O system : Components →Al O , Cr O 2 3 2 3 2 3 2 3 . Component the smallest number of constituent by which the composition of each phase in the system at equilibrium can be expressed in form of chemical formula or equation
  • 62. The number of phases in a system is denoted P (a)A gas, or a gaseous mixture is a single phase. P=1 (b) For a solid system, an alloy of two metals is a two-phase system (P=2) if the metals are immiscible, but a single-phase system (P=1) if they are miscible---a homogeneous mixture of the two substances---is uniform on a molecular scale. (c) For a liquid system, according to the solubility to decide whether a system consists of one phase or of two. For example, a solution of sodium chloride in water is a single phase. A pair of liquids that are partially miscible or immiscible is a two-phase system(P=2) Oil in water
  • 63. A way of understanding the Gibbs Phase Rule: The degrees of freedom can be thought of as the difference between what you (can) control and what the system controls F = C + 2 P Degrees of Freedom = What you can control What the system controls Can control the no. of components added and P & T System decided how many phases to produce given the conditions
  • 64. . F : degree of freedom, the least number of intensive variable that must be fixed (known) to describe the system completely . Degree of freedom (or variance) F is the number of variables (T, p, and/or composition) that can be changed independently without changing the phases of the system a) At the triple point: P = 3 (solid, liquid, and gas) C= 1 (water) P + F = C + 2 F = 0 (no degree of freedom) b) liquid-solid curve P = 2 2+F = 1 + 2 F= 1 One variable (T or P) can be changed c) Liquid P =1 So F =2 Two variables (T and P) can be varied independently and the system will remains a single phase
  • 65. One-component systems Phase diagram of water Curve O-A Vaporization Condensation Critical point 218 Curve O -B Melting 1 Freezing Curve O -C Sublimation 0.006 Deposition =100 =0 O--Triple point 374 F = C P + 2
  • 66. F = C P + 2
  • 67. Phase Diagram of Carbon Dioxide
  • 68. . Condensed system: System in which the vapor phase is ignored and only the solid and/or liquid phases are considered. Two component system . For two component system F can be 3, (3D model is needed), e.g. T , p and concentration , usually we fix p = 1atm , the vapor phase is neglected, and F is reduced to 2 . For three component system the pressure and temperature are fixed
  • 69.
  • 71. Two component system containing liquid phase . Tie Line : bc line: The line at which the system at equilibrium will separate into phases of constant composition, termed ‘conjugate phases’ . Lever Rule: a way to calculate the proportions of each phase present on a phase diagram in a two phase field (at a given temperature and composition). e.g. for point d (24%)
  • 72. e.g. for point d (24%) For every 10 g of liquid system in equilibrium in point d 7.5 g phase A 2.5 g phase B water rich phase contains water+ phenol(11%) Example: Mixed 24g phenol +76g water , T 50°C, equilibrium Phenol rich phase 75 g phase A 25 g phase B contains Phenol (63%)+ water 11% phenol 63 % phenol 0.11× 75 g=8.25 g phenol 0.63× 25 g=15.75 g phenol
  • 73. The Critical Solution Temperature: CST . Is the maximum temperature at which the 2-phase region exists (or upper consolute temperature). . In the case of the phenol-water system, this is 66.8oC (point h) . All combinations of phenol and water > CST are completely miscible and yield 1- phase liquid systems.
  • 74. Systems Showing a Decrease in Miscibility with Rise in Temperature . A few mixtures, exhibit a lower critical solution temperature (low CST), e.g. triethylamine plus water. The miscibility with in temperature.
  • 75. Systems Showing Upper and Lower CSTs The miscibility with temp. a certain temperature miscibility starts to again with further in temperature. Closed-phase diagram, i.e. nicotine-water system.
  • 76. Two component system containing solid and liquid phase (Eutectic Mixtures) B: thymol A :salol 53%
  • 78. Eutectic mixture : Pharmaceutical Application . EMLA® (lidocaine 2.5% and prilocaine 2.5%) Cream . EMLA Cream (lidocaine 2.5% and prilocaine 2.5%) is an emulsion in which the oil phase is a eutectic mixture of lidocaine and prilocaine in a ratio of 1:1 by weight. This eutectic mixture has a melting point below room temperature and therefore both local anesthetics exist as a liquid oil rather than as crystals
  • 79. Three component system Triangular Diagrams for three – component systems
  • 81. Topics that we have covered: 1. Binding Forces Between Molecules 2. Repulsive and Attractive Forces 3. The Gaseous State The Ideal Gas Law Liquefaction of Gases Aerosols 4. Solids and the Crystalline State Crystalline Solids Polymorphism Solvates Amorphous Solids 5. Phase Equilibria and the Phase Rule Phase Rule Systems Containing One Component Condensed System Two-Component Systems Containing Liquid Phases Two-Component Systems Containing Solid and Liquid Phases : Eutectic Mixtures Rules Relating to Triangular Diagrams
  • 83. Study Questions Define the following terms: [solid, liquid, gas, pure substance, compound, mixture, element, heterogeneous mixture, homogeneous mixture, extensive properties, intensive properties, chemical properties, physical properties, density, color, texture, conductivity, malleability, ductility, boiling point, melting point, flammability, corrosiveness, volatility, pounding, tearing, cutting, dissolving, evaporating, fermenting, decomposing, Exothermic, endothermic, mass, density, gravity, adhesive force, cohesive force, etc] Respond to the following questions: ➢What is a mass, inertia, and how do these two variables affect the movement of material substance ➢What is gravity and how does it affect the movement of material substance ➢Give a descriptive account of the phases of matter with logical relevance to state of medicines as they are taken for their respective therapeutical values ➢What is viscosity and its relation with fluids ➢What is surface tension and association with activities a substance material with surface area ➢Describe some key phase changes of materials substance when exposed to some environmental conditions of change ➢How is a chemical change different from a physical change Group work discussional questions: ➢ Give a detailed description Binding Forces Between Molecules ➢ Explain what is meant by Repulsive and Attractive Forces ➢ Explain with examples The Gaseous State of pharmaceutical material ➢ Explain with examples The solid State of pharmaceutical material ➢ Explain with examples The Crystalline State of pharmaceutical material ➢ Explain with examples The liquid State of pharmaceutical material ➢ Explain with examples The semi-solid State of pharmaceutical material ➢ Explain with examples The semi-solid State of pharmaceutical material ➢ Explain with examples The semi-liquid State of pharmaceutical materia